{
    "nctId": "NCT02366806",
    "briefTitle": "Impact of Individualized Radiotherapy Plan Review in Patients Receiving Adjuvant Radiotherapy for Breast Cancer",
    "officialTitle": "Impact of Individualized Radiotherapy Plan Review in Patients Receiving Adjuvant Radiotherapy for Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 72,
    "primaryOutcomeMeasure": "Satisfaction measure",
    "eligibilityCriteria": "Inclusion Criteria\n\n1. Diagnosis of invasive breast cancer\n2. AJCC stage 1, 2, 3 breast carcinoma\n3. Patient deemed clinically appropriate for adjuvant breast or chest wall radiation following surgery\n4. Women of childbearing potential must be non-pregnant and non-lactating and willing to use medically acceptable form of contraception during radiation therapy\n5. Patient must provide study specific informed consent prior to study entry\n6. Breast implants allowed\n\nExclusion Criteria\n\n1. Stage 4 breast cancer\n2. Ductal carcinoma in situ\n3. Patients treated with radiation for palliative intent\n4. Prior treatment with radiation therapy to the ipsilateral breast or chest wall\n5. Prior invasive non-breast malignancy (except non-melanomatous skin cancer, carcinoma in situ of the cervix) unless disease free for a minimum of 5 years prior to study entry\n6. Prior invasive or in-situ carcinoma of the breast (-prior LCIS is eligible)\n7. Diagnosis of DCIS",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}